Form 4: QuantumScape CTO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


QuantumScape's Chief Technology Officer, Timothy Holme, executed multiple sales of Class A Common Stock, including tax-related dispositions and transactions under a pre-arranged 10b5-1 trading plan.

Summary

  • Timothy Holme, QuantumScape's Chief Technology Officer, sold a total of 324,486 shares of Class A Common Stock across several transactions between February 18 and February 20, 2026.
  • Sales included 105,719 shares on February 18, 2026, at a weighted average price of $7.1445, and 23,316 shares on February 19, 2026, at $7.0758, both to cover tax obligations related to restricted stock units (RSUs) and performance restricted stock units (PSUs).
  • An additional 127,077 shares were converted from Class B to Class A Common Stock and then sold on February 19, 2026, at a weighted average price of $7.1013, as part of a Rule 10b5-1 trading plan.
  • The Holme 2020 Irrevocable Trust also converted 34,254 Class B shares to Class A and sold them on February 19, 2026, at $7.1013, under the same 10b5-1 plan.
  • A further 34,120 shares were sold on February 20, 2026, at a weighted average price of $6.9673, also under the Rule 10b5-1 plan.
  • Following these transactions, Mr. Holme directly holds 1,088,228 Class A Common Stock, which includes 978,348 shares represented by RSUs and PSUs, and 7,734,061 Class B Common Stock. The Trust holds 1,449,687 Class B Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider sales can sometimes signal a lack of confidence, the context of tax obligations and a pre-arranged 10b5-1 plan mitigates negative interpretations, making it a routine executive compensation event.

Positives

  • The sales were partially for tax obligations, which is a common and expected event for executives receiving equity compensation.
  • A significant portion of the sales were executed under a pre-arranged Rule 10b5-1 trading plan, indicating the transactions were scheduled in advance and not based on recent non-public information.

Negatives

  • Timothy Holme, a key executive, sold a substantial number of shares (324,486 shares in total), which could be perceived as a reduction in his direct stake in the company's Class A common stock.
  • The sales by The Holme 2020 Irrevocable Trust also represent a reduction in indirect beneficial ownership of Class A common stock.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under Rule 10b5-1 plans or for tax obligations, are common occurrences in the technology sector, especially for executives with significant equity compensation. These types of sales are generally viewed differently than opportunistic sales, as they often reflect pre-planned liquidity events rather than a lack of confidence in the company's future.

Related Party Transactions

  • The sales by The Holme 2020 Irrevocable Trust are considered related party transactions, as the trust is associated with the reporting person, Timothy Holme.

Stakeholder Impact

  • Shareholders: The sale of shares by a key executive could be interpreted by some shareholders as a slight negative, though the context of tax obligations and 10b5-1 plans often tempers such concerns. It does not fundamentally alter the company's operational or strategic direction.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
2025-06-05Date Rule 10b5-1 trading plan was adopted by the reporting person.
2026-02-18Sale of 105,719 Class A Common Stock to cover tax obligations.
2026-02-19Sale of 23,316 Class A Common Stock to cover tax obligations; conversion and sale of 127,077 Class B to Class A Common Stock under 10b5-1 plan; conversion and sale of 34,254 Class B to Class A Common Stock by The Holme 2020 Irrevocable Trust under 10b5-1 plan.
2026-02-20Sale of 34,120 Class A Common Stock under 10b5-1 plan.

Recommendation

hold

The transactions reported are routine insider sales for tax purposes and under a pre-arranged 10b5-1 plan. These do not indicate a change in the company's fundamental prospects or a lack of confidence from the CTO, thus not warranting a change in investment posture based solely on this filing. Investors should continue to hold and monitor QuantumScape's operational performance and broader market trends.

Keywords

QuantumScape, QS, Timothy Holme, Insider Trading, Form 4, Stock Sale, CTO, 10b5-1 Plan, Restricted Stock Units, Performance Stock Units, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.